Genmab — September 2019

E_L

interesting on the liver toxicity which Jan also mentioned before

E_L

and also GEN1042 has initiated according to this

E_L

it was taken out of clinicaltrials a while ago, as you may remember. (I understand on a recent investor conference in Holland, Jan said that it is the next product candidate planned for the clinic)

JohnW

Are GEN1046 and GEN1042 both Genmab products?

JohnW

(hence the prefix?)

E_L

50:50 cost and profit share with Genmab

E_L

with GEN1046 it reads "executed by Genmab" so I guess Genmab mostly in charge

E_L

GEN1042 "We and Genmab began recruitment and screening for a Phase 1/2a trial of GEN1042 (BNT312) for the treatment of malignant solid tumors in August 2019." - so it
started

Sukkeralf

They pulled back the IND and made a CTA instead - so the trial on GEN1042 will be made in Europe

E_L

ah, ok, thanks

E_L

so i guess we keep following this one instead of clinicaltrials US https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-003716-47/DK

Sukkeralf

yes sir

AaBforever

Vi skal sikkert ned i 1270 igen.

E_L

Bryan, Garnier : GENMAB - BUY | DKK1450(+4%)

Data-Driven Medicine is getting more traction

Agreement to identify new disease targets/biomarkers
DDM getting more traction among the pharma/biotech industry
Recipe for success: network is a key

Helge_LarsenPI-redaktør

Et sundstegn at phama falder i kurs: https://penge.borsen.dk/artikel/1/387482/chef_aktieanalytiker_sundhedstegn_for_aktiemarkedet_at_novo_nordisk_falder.html

Vitus

Hvorfor skal vi ikke længere ned end 1270 igen ?

Helge_LarsenPI-redaktør

Fordi på 1.270 går Aab´s Bulls i minus.

Vitus

Det tror jeg nu ikke der bliver taget hensyn til....

StockBull

kun handlet 75000stk så 1270 er nok ikke realistisk her og nu. men ser helst vi slutter over 1350 for der skal nok ikke meget til for at få kursen under 1300 hvis vi går under 1330 idag

Bulder

Ja, beskeden omsætning. Nogen vil dog sælge, men ingen vil købe på det her niveau. Så går det som det går.